Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.

Simon JA, Kingsberg SA, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Clayton AH.

Obstet Gynecol. 2019 Nov;134(5):909-917. doi: 10.1097/AOG.0000000000003514.

PMID:
31599847
2.

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA.

Obstet Gynecol. 2019 Nov;134(5):899-908. doi: 10.1097/AOG.0000000000003500.

PMID:
31599840
3.

Bremelanotide: First Approval.

Dhillon S, Keam SJ.

Drugs. 2019 Sep;79(14):1599-1606. doi: 10.1007/s40265-019-01187-w. Review.

PMID:
31429064
4.

Bremelanotide (Vyleesi) for hypoactive sexual desire disorder.

[No authors listed]

Med Lett Drugs Ther. 2019 Jul 29;61(1577):114-116. Review. No abstract available.

PMID:
31381550
5.

Bremelanotide.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

6.

Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.

Althof S, Derogatis LR, Greenberg S, Clayton AH, Jordan R, Lucas J, Spana C.

J Sex Med. 2019 Aug;16(8):1226-1235. doi: 10.1016/j.jsxm.2019.05.012. Epub 2019 Jul 2.

PMID:
31277966
7.

What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?

Nappi RE, Gardella B.

Expert Opin Pharmacother. 2019 May;20(7):777-779. doi: 10.1080/14656566.2019.1582644. Epub 2019 Feb 26. No abstract available.

PMID:
30806100
8.

Expert opinion on existing and developing drugs to treat female sexual dysfunction.

Miller MK, Smith JR, Norman JJ, Clayton AH.

Expert Opin Emerg Drugs. 2018 Sep;23(3):223-230. doi: 10.1080/14728214.2018.1527901. Epub 2018 Oct 11. Review.

PMID:
30251897
9.

Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis.

Weinberger JM, Houman J, Caron AT, Patel DN, Baskin AS, Ackerman AL, Eilber KS, Anger JT.

Obstet Gynecol. 2018 Aug;132(2):453-458. doi: 10.1097/AOG.0000000000002733.

PMID:
29995725
10.

Effect Size in Efficacy Trials of Women With Decreased Sexual Desire.

Pyke RE, Clayton AH.

Sex Med Rev. 2018 Jul;6(3):358-366. doi: 10.1016/j.sxmr.2018.01.003. Epub 2018 Mar 22. Review.

PMID:
29576442
11.

Evaluation and Management of Hypoactive Sexual Desire Disorder.

Clayton AH, Kingsberg SA, Goldstein I.

Sex Med. 2018 Jun;6(2):59-74. doi: 10.1016/j.esxm.2018.01.004. Epub 2018 Mar 6. Review.

12.

Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder.

Both S.

Curr Sex Health Rep. 2017;9(4):192-199. doi: 10.1007/s11930-017-0124-3. Epub 2017 Oct 19. Review.

13.

Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options.

Croft HA.

J Sex Med. 2017 Dec;14(12):1575-1584. doi: 10.1016/j.jsxm.2017.10.068. Review.

PMID:
29198512
14.

Sexual arousal: Sex matters.

Petherick A.

Nature. 2017 Oct 4;550(7674):S2-S3. doi: 10.1038/550S2a. No abstract available.

PMID:
28976951
15.

Flibanserin for hypoactive sexual desire disorder: place in therapy.

Gelman F, Atrio J.

Ther Adv Chronic Dis. 2017 Jan;8(1):16-25. doi: 10.1177/2040622316679933. Epub 2017 Jan 18. Review.

16.

Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants.

Clayton AH, Lucas J, DeRogatis LR, Jordan R.

Clin Ther. 2017 Mar;39(3):514-526.e14. doi: 10.1016/j.clinthera.2017.01.018. Epub 2017 Feb 9.

17.

Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide.

White WB, Myers MG, Jordan R, Lucas J.

J Hypertens. 2017 Apr;35(4):761-768. doi: 10.1097/HJH.0000000000001221.

18.

Re: Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial.

Seftel AD.

J Urol. 2016 Nov;196(5):1516-1517. doi: 10.1016/j.juro.2016.08.063. Epub 2016 Aug 23. No abstract available.

PMID:
27751477
19.

Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.

Clayton AH, Althof SE, Kingsberg S, DeRogatis LR, Kroll R, Goldstein I, Kaminetsky J, Spana C, Lucas J, Jordan R, Portman DJ.

Womens Health (Lond). 2016 Jun;12(3):325-37. doi: 10.2217/whe-2016-0018. Epub 2016 May 16.

20.

Supplemental Content

Loading ...
Support Center